SR
Sirisha Rosy Neturi
About Sirisha Rosy Neturi
Data last updated:
Sirisha Rosy Neturi has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Dr Siva Prasad Heart Clinics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Dr Siva Prasad Heart Clinics Private Limited at ₹10.93 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dr Siva Prasad Heart Clinics Private Limited U85300AP2021PTC118947 | Director | 27 Jul 2021 | 2021 | ₹10.93 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sirisha Rosy Neturi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sirisha Rosy Neturi
Sirisha Rosy Neturi has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Dr Siva Prasad Heart Clinics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Dr Siva Prasad Heart Clinics Private Limited at ₹10.93 Cr (FY 2024).
Sirisha Rosy Neturi is associated with 1 company as Director, including Dr Siva Prasad Heart Clinics Private Limited (₹10.93 Cr).
Sirisha Rosy Neturi has expertise in General Business.
Sirisha Rosy Neturi has 5 years in corporate governance.
By reported revenue, the largest current company of Sirisha Rosy Neturi is Dr Siva Prasad Heart Clinics Private Limited, with revenue of ₹10.93 Cr (FY 2024).
Sirisha Rosy Neturi currently holds positions at 1 company: Dr Siva Prasad Heart Clinics Private Limited (₹10.93 Cr).